Drug Approval Package

 Cardizem LA (Diltiazem HCI) Extended Release Tablets
Company:  Biovail Laboratories, Inc.
Application No.:  021392
Approval Date: 2/6/2003

• Approval Letter(s) (PDF)

• Printed Labeling (PDF)

• Medical Review(s) (PDF)  

• Chemistry Review(s) (PDF)

• Pharmacology Review(s) (PDF)  

• Statistical Review(s) (PDF)

• Clinical Pharmacology Biopharmaceutics Review(s) (PDF)

• Administrative Document(s) & Correspondence (PDF)  

Date created: June 272005

Back to Top    Drugs@FDA

Note: Documents in PDF format require the Adobe Acrobat Reader®.